Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

Marie Skłodowska-Curie Action · Running

INNOVISION Innovation in Vision Research Postdoctoral Training Network

Coordinator
South East Technological University, Ireland
Runs
1 January 2026 to 31 December 2030
Status
Running
EU funding
€1.7m
Total cost
—
Partners
18 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101217199

What the project is doing

In the project's own words, from its summary on CORDIS.

With the increasing global incidence of vision impairment and ocular disease due to aging, chronic disease, and environmental factors, the need for pioneering, interdisciplinary and intersectoral research in vision science has never been greater. The 60-month INNOVISION Programme will recruit, train, and accelerate the careers of 12 research fellows in innovative, cutting-edge techniques to tackle ocular disease and vision impairment.

Each researcher will be recruited for 30 months as full-time employees, with two calls throughout the programme recruiting six researchers each. INNOVISION will adhere to best practices in recruitment and employment, aligning to the EU’s Charter and Code for Researchers. The complexity of ocular disease demands a multifaceted approach to research that transcends traditional, siloed disciplinary boundaries. INNOVISION uses the “bottom up” research approach to address this, allowing researchers to select their supervisor, design their project, determine their secondments, and build both themselves as researchers, as well as their project goals and aims.

As such, INNOVISION ingrains insights from various fields such as nanomedicine, genetics, pharmacology, chemistry, molecular biology, psychology, medicine, veterinary medicine, engineering, ophthalmology, artificial intelligence, and social sciences such as global and public health and ethnographic studies (among others), into the comprehensive training programme. Collaboration across sectors—such as academia, industry, and patient advocacy groups—ensures that research findings are not only scientifically robust but also practically applicable, facilitating the translation of discoveries from the lab to the clinic.

Equally important is the need to reach out to the public and incorporate Patient and Public Involvement (PPI) initiatives, which ensure that research is aligned with the real-world needs and priorities of those directly affected by ocular disease and vision impairment.

Topics

Who is involved

OrganisationCityCountryRole
South East Technological UniversityWaterfordIrelandCoordinator
Mcmaster UniversityHamiltonCanadaAssociatedpartner
University of WaterlooWaterlooCanadaAssociatedpartner
Universidad Complutense De MadridMadridSpainAssociatedpartner
Universidad De Santiago De CompostelaSantiago De CompostelaSpainAssociatedpartner
Bausch & LOMB IRELAND LIMITEDWaterfordIrelandAssociatedpartner
Fighting BlindnessDublinIrelandAssociatedpartner
OcuDel LimitedDublinIrelandAssociatedpartner
Siriusxt LimitedDublinIrelandAssociatedpartner
University College Dublin, National University of Ireland, DublinDublinIrelandAssociatedpartner
Instituto Superior TecnicoLisboaPortugalAssociatedpartner
The Queen's University of BelfastBelfastUnited KingdomAssociatedpartner
The University of BirminghamBirminghamUnited KingdomAssociatedpartner
Loyola University of ChicagoChicagoUnited StatesAssociatedpartner
OcuMedic Inc.Mullica HillUnited StatesAssociatedpartner
Regents of the University of ColoradoBoulder CoUnited StatesAssociatedpartner
Rowan UniversityGlassboroUnited StatesAssociatedpartner
The Dry Eye FoundationPoulsboUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI